Recent Study Explores Hepatitis C Industry Pipeline Review, H2 2017

Overview

Hepatitis C is a contagious viral infection affecting the liver. It may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea and vomiting The predisposing factors of hepatitis C include dialysis, organ transplant and blood transfusion. Offspring of an infected mother also has high chances of contracting the disease. Hepatitis C can be controlled with the help of medications or a transplant at an advanced stage.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/2319073-west-nile-virus-infections-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Hepatitis C - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Hepatitis C (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hepatitis C (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 13, 20, 16, 1, 50, 47 and 4 respectively. Similarly, the Universities portfolio in Phase II, IND/CTA Filed, Preclinical and Discovery stages comprises 3, 1, 9 and 21 molecules, respectively.

 Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Hepatitis C (Infectious Disease). 
- The pipeline guide reviews pipeline therapeutics for Hepatitis C (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in Hepatitis C (Infectious Disease) therapeutics and enlists all their major and minor projects.   

Table of Contents 

Table of Contents 2 
Introduction 6 
Hepatitis C - Overview 7 
Hepatitis C - Therapeutics Development 8 
Hepatitis C - Therapeutics Assessment 29 
Hepatitis C - Companies Involved in Therapeutics Development 39 
Hepatitis C - Drug Profiles 68 
Hepatitis C - Dormant Projects 394 
Hepatitis C - Discontinued Products 411 
Hepatitis C - Product Development Milestones 416 
Appendix 429

List of Tables 
Number of Products under Development for Hepatitis C, H2 2017 
Number of Products under Development by Companies, H2 2017 
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 
Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017 
Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017 
Number of Products under Development by Companies, H2 2017 (Contd..4), H2 2017 
Number of Products under Development by Universities/Institutes, H2 2017 

  .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2319073-west-nile-virus-infections-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.